Saliva test may predict psychedelic therapy success for depression

This study looks at whether a hormone called oxytocin, measured in saliva during a psychedelic therapy session, can help predict how well people with major depression respond to treatment. Researchers will track changes in depression symptoms, flexibility in thinking, and anxiety in 80 adults. The goal is to better understand how psychedelic therapy works, not to test a new treatment.